Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Coitus × lenvatinib × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Conditions

Carcinoma, Hepatocellular 99 Cholangiocarcinoma 22 Carcinoma, Renal Cell 16 Liver Neoplasms 10 Biliary Tract Neoplasms 9 Stomach Neoplasms 8 Endometrial Neoplasms 7 Breast Neoplasms 7 Thyroid Neoplasms 6 Neoplasms 6 Recurrence 5 Uterine Cervical Neoplasms 4 Melanoma 4 Thyroid Cancer, Papillary 3 Pancreatic Neoplasms 3 Ovarian Neoplasms 3 Neuroendocrine Tumors 3 Neoplasm Metastasis 3 Cirrhosis, Familial, with Pulmonary Hypertension 3 Advanced Biliary Tract Cancer 3 Adenocarcinoma, Follicular 3 Adenocarcinoma 3 Uveal Melanoma 2 Thyroid Carcinoma, Anaplastic 2 Small Cell Lung Carcinoma 2 Sarcoma 2 Paraganglioma, Extra-Adrenal 2 Mesothelioma, Malignant 2 Liver Diseases 2 Kidney Neoplasms 2

Interventions

Surveys and Questionnaires 2 oncomodulin 1 lenvatinib 1 Sex 1 Proctectomy 1 Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 1 Gastrectomy 1 Focus Groups 1 Exercise Test 1 Blood Specimen Collection 1 Aging 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05789667 2024-12-06

Gisel

Regina Elena Cancer Institute

Coitus

Data powered by HemOnc (CC BY 4.0) Colophon ⚡